Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

GGYRE THERAPEUTICS, INC.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
G

GYRE THERAPEUTICS, INC.

  • Overview
  • Financial statements
  • Metrics
    • Revenue & profit
    • Revenue by segment
    • Launches
    • Revenue concentration
    • Margins
    • Contracted revenue
    • Off-balance-sheet commitments
    • Cash flow
    • Cash & debt
    • Earnings per share
    • P/E ratio
    • Share count & dilution
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions
Loading financial graphs

Metrics

Revenue & profit
Revenue by segment
Margins
Contracted revenue
Cash flow
Cash & debt
Earnings per share
Share count & dilution

Metrics

Compare sales with the profit left after direct costs and the profit left after all expenses and taxes.Formula: Gross profit = revenue − cost of revenue Net income = total income − total expenses
Q2 ’26201720182019202020212022202320242025-100M-50M0Latest period Q2 '26. Revenue 29.11M. Gross profit 26.9M. Net profit -17.94M.
RevenueGross profitNet profit
See which business lines, products, or regions generate the company’s sales.Formula: Company revenue = Σ(segment revenues) + reconciliation adjustments
Q2 ’26201720182019202020212022202320242025010M20M30MLatest period Q2 '26. Gyre 8K. Gyre Pharmaceuticals 29.1M.
Collaboration RevenueLicense RevenueExclusive LicenseAll Other SegmentsGyreGyre Pharmaceuticals
See how much of the company’s revenue comes from each customer it reports as 10% or more of revenue. Filings often name these customers only as Customer A, Customer B, and so on.Formula: Customer share = customer revenue ÷ total revenue × 100% Other customers = 100% − Σ(major customer shares)
Q2 ’262017201820192020202120222023202420250%20%40%60%80%100%
      Latest period Q2 '26. Sinopharm Group Company Limited 48.7%. China Resources Pharmaceutical Group Limited 11.6%. Shanghai Pharmaceuticals Holding Company Limited 12.2%. Other customers 27.5%.
      Sinopharm Group Company LimitedChina Resources Pharmaceutical Group LimitedShanghai Pharmaceuticals Holding Company LimitedOther customers
      See how much of each dollar of sales remains after direct costs, after running the business, and after all expenses and taxes.Formula: Gross margin = gross profit ÷ revenue × 100% Operating margin = operating income ÷ revenue × 100% Net margin = net income ÷ revenue × 100%
      Q2 ’26201720182019202020212022202320242025-100,000%-80,000%-60,000%-40,000%-20,000%0%Latest period Q2 '26. Gross margin 92.4%. Operating margin -49.3%. Net profit margin -61.6%.
      Gross marginOperating marginNet profit marginNo revenue (margins undefined)
      Compare cash generated by the business, spending on long-lived assets, and what remains afterward.Formula: Free cash flow = operating cash flow − capital expenditures
      $
      Q2 ’26201720182019202020212022202320242025-20M020M40M
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        Latest period Q2 '26. Operating cash flow -16.7M. Capex -262K. Free cash flow -17M.
        Operating cash flowCapexFree cash flow
        Compare the company’s cash cushion with its borrowings. Negative net cash means debt is greater than cash.Formula: Net cash = cash − debt
        2026201720182019202020212022202320242025020M40M60M80M100M120M
            Latest period 2026. Cash 43.3M. Debt 0.
            CashDebtNet cash
            Profit for each share over the trailing 12 months, adjusted for stock splits.Formula: Earnings available to common shareholders ÷ weighted-average shares
            $/shareUsing split history cached 2026-09-23; assuming no new splits
            Q2 ’26201720182019202020212022202320242025-250.00-200.00-150.00-100.00-50.000.00
              • Earnings period 2017-01-01 to 2017-03-31. Shares as of 2017-03-31: 1,000,036 source shares.
              • Earnings period 2017-04-01 to 2017-06-30. Shares as of 2017-06-30: 4,310,561 source shares.
              • Earnings period 2017-07-01 to 2017-09-30. Shares as of 2017-09-30: 4,310,561 source shares.
              • Earnings period 2017-01-01 to 2017-12-31. Shares as of 2017-12-31: 6,081,230 source shares.
              • Earnings period 2018-01-01 to 2018-03-31. Shares as of 2018-03-31: 11,935,081 source shares.
              • Earnings period 2018-04-01 to 2018-06-30. Shares as of 2018-06-30: 11,942,729 source shares.
              • Earnings period 2018-07-01 to 2018-09-30. Shares as of 2018-09-30: 11,942,729 source shares.
              • Earnings period 2018-01-01 to 2018-12-31. Shares as of 2018-12-31: 11,954,528 source shares.
              • Earnings period 2019-01-01 to 2019-03-31. Shares as of 2019-03-31: 11,974,104 source shares.
              • Earnings period 2019-04-01 to 2019-06-30. Shares as of 2019-06-30: 12,008,528 source shares.
              • Earnings period 2019-07-01 to 2019-09-30. Shares as of 2019-09-30: 12,029,992 source shares.
              • Earnings period 2019-01-01 to 2019-12-31. Shares as of 2019-12-31: 12,040,835 source shares.
              • Earnings period 2020-01-01 to 2020-03-31. Shares as of 2020-03-31: 17,419,313 source shares.
              • Earnings period 2020-04-01 to 2020-06-30. Shares as of 2020-06-30: 22,050,745 source shares.
              • Earnings period 2020-07-01 to 2020-09-30. Shares as of 2020-09-30: 22,082,924 source shares.
              • Earnings period 2020-01-01 to 2020-12-31. Shares as of 2020-12-31: 22,097,820 source shares.
              • Earnings period 2021-01-01 to 2021-03-31. Shares as of 2021-03-31: 31,331,027 source shares.
              • Earnings period 2021-04-01 to 2021-06-30. Shares as of 2021-06-30: 31,349,740 source shares.
              • Earnings period 2021-07-01 to 2021-09-30. Shares as of 2021-09-30: 22,097,820 source shares.
              • Earnings period 2021-01-01 to 2021-12-31. Shares as of 2021-12-31: 31,409,707 source shares.
              • Earnings period 2022-01-01 to 2022-03-31. Shares as of 2022-03-31: 31,477,053 source shares.
              • Earnings period 2022-04-01 to 2022-06-30. Shares as of 2022-06-30: 31,477,053 source shares.
              • Earnings period 2022-07-01 to 2022-09-30. Shares as of 2022-09-30: 31,490,053 source shares.
              • Earnings period 2022-01-01 to 2022-12-31. Shares as of 2022-12-31: 63,588,119 source shares.
              • Earnings period 2023-01-01 to 2023-03-31. Shares as of 2023-03-31: 37,759,825 source shares.
              • Earnings period 2023-04-01 to 2023-06-30. Shares as of 2023-06-30: 37,974,892 source shares.
              • Earnings period 2023-07-01 to 2023-09-30. Shares as of 2023-09-30: 37,978,142 source shares.
              • Earnings period 2023-01-01 to 2023-12-31. Shares as of 2023-12-31: 76,595,616 source shares.
              • Earnings period 2024-01-01 to 2024-03-31. Shares as of 2024-03-31: 85,423,246 source shares.
              • Earnings period 2024-04-01 to 2024-06-30. Shares as of 2024-06-30: 85,537,774 source shares.
              • Earnings period 2024-07-01 to 2024-09-30. Shares as of 2024-09-30: 85,769,526 source shares.
              • Earnings period 2024-01-01 to 2024-12-31. Shares as of 2024-12-31: 86,307,544 source shares.
              • Earnings period 2025-01-01 to 2025-03-31. Shares as of 2025-03-31: 87,636,209 source shares.
              • Earnings period 2025-04-01 to 2025-06-30. Shares as of 2025-06-30: 90,822,828 source shares.
              • Earnings period 2025-07-01 to 2025-09-30. Shares as of 2025-09-30: 90,890,381 source shares.
              • Earnings period 2025-01-01 to 2025-12-31. Shares as of 2025-12-31: 91,314,007 source shares.
              • Earnings period 2026-01-01 to 2026-03-31. Shares as of 2026-03-31: 91,337,121 source shares.
              • Earnings period 2026-04-01 to 2026-06-30. Shares as of 2026-06-30: 106,033,763 source shares.
              Latest period Q2 2026. EPS (TTM) -0.17.
              EPS (TTM)
              How much investors pay for each dollar of the company’s yearly earnings. It is not useful when the company has no profit.Formula: Share price ÷ trailing 12-month EPS
              Using split history cached 2026-09-23; assuming no new splits
              Security type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingQ2 ’262017201820192020202120222023202420250x0.2x0.4x0.6x0.8x1x
              • Q1 2017: Security type not verified
              • Q2 2017: Security type not verified
              • Q3 2017: Security type not verified
              • FY 2017: Security type not verified
              • Q1 2018: Security type not verified
              • Q2 2018: Security type not verified
              • Q3 2018: Security type not verified
              • FY 2018: Security type not verified
              • Q1 2019: Security type not verified
              • Q2 2019: Security type not verified
              • Q3 2019: Security type not verified
              • FY 2019: Security type not verified
              • Q1 2020: Security type not verified
              • Q2 2020: Security type not verified
              • Q3 2020: Security type not verified
              • FY 2020: Security type not verified
              • Q1 2021: Security type not verified
              • Q2 2021: Security type not verified
              • Q3 2021: Security type not verified
              • FY 2021: Security type not verified
              • Q1 2022: Security type not verified
              • Q2 2022: Security type not verified
              • Q3 2022: Security type not verified
              • FY 2022: Security type not verified
              • Q1 2023: Security type not verified
              • Q2 2023: Security type not verified
              • Q3 2023: Security type not verified
              • FY 2023: Security type not verified
              • Q1 2024: Security type not verified
              • Q2 2024: Security type not verified
              • Q3 2024: Security type not verified
              • FY 2024: Security type not verified
              • Q1 2025: Security type not verified
              • Q2 2025: Security type not verified
              • Q3 2025: Security type not verified
              • FY 2025: Security type not verified
              • Q1 2026: Security type not verified
              • Q2 2026: Security type not verified
              • Earnings period 2017-01-01 to 2017-03-31. Shares as of 2017-03-31: 1,000,036 source shares.
              • Earnings period 2017-04-01 to 2017-06-30. Shares as of 2017-06-30: 4,310,561 source shares.
              • Earnings period 2017-07-01 to 2017-09-30. Shares as of 2017-09-30: 4,310,561 source shares.
              • Earnings period 2017-01-01 to 2017-12-31. Shares as of 2017-12-31: 6,081,230 source shares.
              • Earnings period 2018-01-01 to 2018-03-31. Shares as of 2018-03-31: 11,935,081 source shares.
              • Earnings period 2018-04-01 to 2018-06-30. Shares as of 2018-06-30: 11,942,729 source shares.
              • Earnings period 2018-07-01 to 2018-09-30. Shares as of 2018-09-30: 11,942,729 source shares.
              • Earnings period 2018-01-01 to 2018-12-31. Shares as of 2018-12-31: 11,954,528 source shares.
              • Earnings period 2019-01-01 to 2019-03-31. Shares as of 2019-03-31: 11,974,104 source shares.
              • Earnings period 2019-04-01 to 2019-06-30. Shares as of 2019-06-30: 12,008,528 source shares.
              • Earnings period 2019-07-01 to 2019-09-30. Shares as of 2019-09-30: 12,029,992 source shares.
              • Earnings period 2019-01-01 to 2019-12-31. Shares as of 2019-12-31: 12,040,835 source shares.
              • Earnings period 2020-01-01 to 2020-03-31. Shares as of 2020-03-31: 17,419,313 source shares.
              • Earnings period 2020-04-01 to 2020-06-30. Shares as of 2020-06-30: 22,050,745 source shares.
              • Earnings period 2020-07-01 to 2020-09-30. Shares as of 2020-09-30: 22,082,924 source shares.
              • Earnings period 2020-01-01 to 2020-12-31. Shares as of 2020-12-31: 22,097,820 source shares.
              • Earnings period 2021-01-01 to 2021-03-31. Shares as of 2021-03-31: 31,331,027 source shares.
              • Earnings period 2021-04-01 to 2021-06-30. Shares as of 2021-06-30: 31,349,740 source shares.
              • Earnings period 2021-07-01 to 2021-09-30. Shares as of 2021-09-30: 22,097,820 source shares.
              • Earnings period 2021-01-01 to 2021-12-31. Shares as of 2021-12-31: 31,409,707 source shares.
              • Earnings period 2022-01-01 to 2022-03-31. Shares as of 2022-03-31: 31,477,053 source shares.
              • Earnings period 2022-04-01 to 2022-06-30. Shares as of 2022-06-30: 31,477,053 source shares.
              • Earnings period 2022-07-01 to 2022-09-30. Shares as of 2022-09-30: 31,490,053 source shares.
              • Earnings period 2022-01-01 to 2022-12-31. Shares as of 2022-12-31: 63,588,119 source shares.
              • Earnings period 2023-01-01 to 2023-03-31. Shares as of 2023-03-31: 37,759,825 source shares.
              • Earnings period 2023-04-01 to 2023-06-30. Shares as of 2023-06-30: 37,974,892 source shares.
              • Earnings period 2023-07-01 to 2023-09-30. Shares as of 2023-09-30: 37,978,142 source shares.
              • Earnings period 2023-01-01 to 2023-12-31. Shares as of 2023-12-31: 76,595,616 source shares.
              • Earnings period 2024-01-01 to 2024-03-31. Shares as of 2024-03-31: 85,423,246 source shares.
              • Earnings period 2024-04-01 to 2024-06-30. Shares as of 2024-06-30: 85,537,774 source shares.
              • Earnings period 2024-07-01 to 2024-09-30. Shares as of 2024-09-30: 85,769,526 source shares.
              • Earnings period 2024-01-01 to 2024-12-31. Shares as of 2024-12-31: 86,307,544 source shares.
              • Earnings period 2025-01-01 to 2025-03-31. Shares as of 2025-03-31: 87,636,209 source shares.
              • Earnings period 2025-04-01 to 2025-06-30. Shares as of 2025-06-30: 90,822,828 source shares.
              • Earnings period 2025-07-01 to 2025-09-30. Shares as of 2025-09-30: 90,890,381 source shares.
              • Earnings period 2025-01-01 to 2025-12-31. Shares as of 2025-12-31: 91,314,007 source shares.
              • Earnings period 2026-01-01 to 2026-03-31. Shares as of 2026-03-31: 91,337,121 source shares.
              • Earnings period 2026-04-01 to 2026-06-30. Shares as of 2026-06-30: 106,033,763 source shares.
              Latest period Q2 2026. P/E ratio Missing.
              P/E ratio
              See how the number of shares changes over time. More shares can mean each existing share owns a smaller slice of the company.Formula: Outstanding shares = issued shares − treasury shares Share-count growth = (current shares ÷ previous shares − 1) × 100%
              Stock split history may be out of date.
              2026201720182019202020212022202320242025020M40M60M80M100M
              2017-02-13: Reverse stock split 1-for-15
              2023-10-31: Reverse stock split 1-for-15
                  Latest period 2026. Shares outstanding 106M. Class detail unavailable 106M.
                  Class detail unavailableStock split